Lymphoproliferative Disease After Pediatric Liver Transplant

Exp Clin Transplant. 2017 Mar;15(Suppl 2):79-81. doi: 10.6002/ect.TOND16.L22.

Abstract

Posttransplant lymphoproliferative disease is a major complication following solid-organ transplant. We summarize the relation of Epstein-Barr virus to this complication and discuss its treatment in pediatric patients.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Epstein-Barr Virus Infections / immunology
  • Epstein-Barr Virus Infections / pathology
  • Epstein-Barr Virus Infections / therapy
  • Epstein-Barr Virus Infections / virology*
  • Herpesvirus 4, Human / immunology
  • Herpesvirus 4, Human / pathogenicity*
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Liver Transplantation / adverse effects*
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / pathology
  • Lymphoproliferative Disorders / therapy
  • Lymphoproliferative Disorders / virology*
  • Risk Factors
  • Treatment Outcome
  • Virus Activation

Substances

  • Immunosuppressive Agents